Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novadel Pharma Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Novadel Pharma Inc since year 2005.
Table 2 shows the detailed insider transactions of Novadel Pharma Inc since 2005.
The reporting company's ticker symbol is NVD. The reporting company's CIK number is 1043873.
The total value of stock buying since 2005 is $4,925,527.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2010-03-31||Proquest Associates Ii Llc (10% Owner)||Buy||4,848,485||.16||800,000|
|2009-12-11||Ratoff Steven B (Chief Executive Officer)||Buy||500,000||.15||76,500|
|2009-12-08||Ratoff Steven B (Chief Executive Officer)||Buy||500,000||.14||72,500|
|2007-08-30||Bonney Thomas E (Director)||Buy||5,300||.79||4,187|
|2007-08-30||Hamilton William F Phd (Director)||Buy||4,000||.80||3,200|
|2007-08-29||Baric Mark J (Director)||Buy||4,900||.80||3,920|
|2007-08-28||Baric Mark J (Director)||Buy||100||.69||69|
|2007-08-28||Hamilton William F Phd (Director)||Buy||5,000||.68||3,400|
|2007-08-28||Ratoff Steven B (Director)||Buy||5,910||.73||4,308|
|2007-08-27||Nemeroff Charles (Director)||Buy||15,000||.68||10,200|
|2007-08-24||Bergstrom David H (SVP & Chief Operating Officer)||Buy||40,000||.65||26,040|
|2007-08-24||Ratoff Steven B (Director)||Buy||6,300||.65||4,095|
|2007-08-23||Ratoff Steven B (Director)||Buy||39,300||.65||25,545|
|2007-08-22||Ratoff Steven B (Director)||Buy||4,400||.64||2,829|
|2007-08-21||Ratoff Steven B (Director)||Buy||50,000||.61||30,350|
|2007-08-20||Spicer Michael E B (CFO and Corporate Secretary)||Buy||30,000||.64||19,290|
|2007-08-20||Ratoff Steven B (Director)||Buy||25,000||.60||14,925|
|2007-01-05||Proquest Associates Iii Llc (10% Owner)||Buy||763,449||1.45||1,107,001|
|2007-01-05||Schreiber Alain (10% Owner)||Buy||961,914||1.45||1,394,775|
|2006-06-30||Bonney Thomas E (Director)||Buy||19,500||1.32||25,740|
|2006-06-23||Spicer Michael E B (Chief Financial Officer)||Buy||1,500||1.38||2,070|
|2006-04-19||Lobell J Jay (Director)||Buy||31,646||1.58||50,000|
|2006-04-19||Ratoff Steven B (Director)||Buy||129,090||1.58||203,962|
|2006-04-12||Schreiber Alain (10% Owner)||Buy||689,656||1.45||1,000,001|
|2005-12-29||Spicer Michael E B (Chief Financial Officer)||Buy||5,000||1.18||5,900|
|2005-06-30||Spicer Michael E B (Chief Financial Officer)||Buy||2,500||1.20||3,000|
|2005-06-29||Shangold Gary A (CEO)||Buy||26,000||1.22||31,720|
Insider trading activities including stock purchases, stock sales, and option exercises of NVD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Novadel Pharma Inc (symbol NVD, CIK number 1043873) see the Securities and Exchange Commission (SEC) website.